Abstract
The early B-cell factor (EBF)-associated zinc-finger protein (EBFAZ) binds to and negatively regulates EBF, a basic helix–loop–helix transcription factor required for B-cell lineage commitment and development of the olfactory epithelium. It also binds to SMA- and MAD-related protein 1 (SMAD1) and SMAD4 in response to bone morphogenic protein 2 (BMP2) signaling. It is highly related to ecotropic viral integration site 3 (EVI3), a protein that, like EBFAZ, contains 30 Krüppel-like zinc-finger repeats. In previous studies, we showed that Evi3 is a frequent target of retroviral integration in AKXD27 B-cell lymphomas. Here, we show that EBFAZ is also a frequent target. Integrations at Ebfaz and Evi3 are mutually exclusive, suggesting that they function in the same tumor pathway. Lymphomas with integrations at Ebfaz or Evi3 express the pre-B-cell-specific marker immunoglobulin lambda chain 5, and contain immunoglobulin heavy-chain rearrangements, suggesting that they are blocked at an early B-cell stage. Unlike Evi3, which is expressed at low levels in normal B cells, or Ebfaz, which is not expressed in B cells, both genes are highly expressed following viral integration. Collectively, our results suggest that ectopic expression of Ebfaz can substitute for the upregulated expression of Evi3 in B-cell disease and highlight the importance of this gene family in hematopoietic cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Coffman RL and Weissman IL . (1981). Nature, 289, 681–683.
Gilbert DJ, Neumann PE, Taylor BA, Jenkins NA and Copeland NG . (1993). J. Virol., 67, 2083–2090.
Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A and Massague J . (2000). Cell, 100, 229–240.
Heerema NA, Sather HN, Ge J, Arthur DC, Hilden JM, Trigg ME and Reaman GH . (1999). Leukemia, 13, 679–686.
Hiai H, Tsuruyama T and Yamada Y . (2003). Cancer Sci., 94, 847–850.
Hilden JM, Frestedt JL, Moore RO, Heerema NA, Arthur DC, Reaman GH and Kersey JH . (1995). Blood, 86, 3876–3882.
Justice MJ, Morse III HC, Jenkins NA and Copeland NG . (1994). J. Virol., 68, 1293–1300.
Kudo A and Melchers F . (1987). EMBO J., 6, 2267–2272.
Li J, Shen H, Himmel KL, Dupuy AJ, Largaespada DA, Nakamura T, Shaughnessy Jr JD, Jenkins NA and Copeland NG . (1999). Nat. Genet., 23, 348–353.
Mucenski ML, Taylor BA, Jenkins NA and Copeland NG . (1986). Mol. Cell. Biol., 6, 4236–4243.
Sakaguchi N and Melchers F . (1986). Nature, 324, 579–582.
Schebesta M, Heavey B and Busslinger M . (2002). Curr. Opin. Immunol., 14, 216–223.
Seong C, Delasalle K, Hayes K, Weber D, Dimopoulos M, Swantkowski J, Huh Y, Glassman A, Champlin R and Alexanian R . (1998). Br. J. Haematol., 101, 189–194.
Sigvardsson M, O'Riordan M and Grosschedl R . (1997). Immunity, 7, 25–36.
Smadja NV, Bastard C, Brigaudeau C, Leroux D and Fruchart C . (2001). Blood, 98, 2229–2238.
Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ, Jenkins NA and Copeland NG . (2002). Nat. Genet., 19, 19.
Tsai RY and Reed RR . (1997). J. Neurosci., 17, 4159–4169.
Tsai RY and Reed RR . (1998). Mol. Cell. Biol., 18, 6447–6456.
Warming S, Liu P, Suzuki T, Akagi K, Lindtner S, Pavlakis GN, Jenkins NA and Copeland NG . (2003). Blood, 101, 1934–1940.
Acknowledgements
We thank Kristin Biris for help with in situ hybridization and Linda Cleveland for DNA sequencing. We also thank James Cherry, Kelly Martin, Casey Frankenberger and David Munroe from the Gene Expression Laboratory, NCI-Frederick, for help with the real-time RT–PCR. This research was supported by the National Cancer Institute, US Department of Health and Human Services (NAJ, TPY and NGC) and the Danish Natural Science Research Council (SW).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Warming, S., Suzuki, T., Yamaguchi, T. et al. Early B-cell factor-associated zinc-finger gene is a frequent target of retroviral integration in murine B-cell lymphomas. Oncogene 23, 2727–2731 (2004). https://doi.org/10.1038/sj.onc.1207452
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207452
Keywords
This article is cited by
-
The stem cell-associated transcription co-factor, ZNF521, interacts with GLI1 and GLI2 and enhances the activity of the Sonic hedgehog pathway
Cell Death & Disease (2019)
-
DmOAZ, the unique Drosophila melanogaster OAZ homologue is involved in posterior spiracle development
Development Genes and Evolution (2007)